|
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
RECRUITINGSponsored by Columbia University
Actively Recruiting
SponsorColumbia University
Started2011-01-31
Est. completion2026-12-31
Eligibility
Healthy vol.Accepted
Locations16 sites
View on ClinicalTrials.gov →
NCT01694940
Summary
The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients with mitochondrial disorders.
Eligibility
Healthy volunteers accepted
Inclusion Criteria: * Patients diagnosed with or suspected to have a mitochondrial disorder * Adult carriers of known mitochondrial DNA mutations * Patients with laboratory analysis indicative of a mitochondrial disorder. * Medical information and tissue samples are also accepted from deceased individuals who fulfill the above criteria. Exclusion Criteria: * Patients not suspected of having a mitochondrial disorder * Patients not suspected of carrying a mitochondrial DNA or nuclear DNA mutation that affects mitochondrial function.
Conditions7
Deletion and Duplication of Mitochondrial DNADiabetesDisorder of Mitochondrial Respiratory Chain ComplexesHeart DiseaseMitochondrial DiseasesMitochondrial DisordersMitochondrial Genetic Disorders
Locations16 sites
University of California San Diego
San Diego, California, 92103
Lucile Packard Children's Hospital
Stanford, California, 94305
Gregory Enns, MD1-650-723-6858
Children's Hospital of Colorado
Aurora, Colorado, 80045
Johan Van Hove, MD PhD MBA3037242351
Children's National Medical Center
Washington D.C., District of Columbia, 20010
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorColumbia University
Started2011-01-31
Est. completion2026-12-31
Eligibility
Healthy vol.Accepted
Locations16 sites
View on ClinicalTrials.gov →
NCT01694940